Your browser doesn't support javascript.
loading
PCSK9 Inhibitors in a German Single-Center Clinical Practice: Real-World Treatment of Patients at High Cardiovascular Risk Over 68 Weeks.
Hollstein, Tim; Kassner, Ursula; Grenkowitz, Thomas; Schumann, Friederike; Bobbert, Thomas; Steinhagen-Thiessen, Elisabeth.
Afiliación
  • Hollstein T; Division of Lipid Disorders, Department of Endocrinology, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, Ostring 3, 13353, Berlin, Germany.
  • Kassner U; Division of Lipid Disorders, Department of Endocrinology, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, Ostring 3, 13353, Berlin, Germany.
  • Grenkowitz T; Division of Lipid Disorders, Department of Endocrinology, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, Ostring 3, 13353, Berlin, Germany.
  • Schumann F; Division of Lipid Disorders, Department of Endocrinology, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, Ostring 3, 13353, Berlin, Germany.
  • Bobbert T; Division of Lipid Disorders, Department of Endocrinology, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, Ostring 3, 13353, Berlin, Germany.
  • Steinhagen-Thiessen E; Division of Lipid Disorders, Department of Endocrinology, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, Ostring 3, 13353, Berlin, Germany. elisabeth.steinhagen-thiessen@charite.de.
Am J Cardiovasc Drugs ; 21(1): 83-92, 2021 Jan.
Article en En | MEDLINE | ID: mdl-32514867

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Inhibidores de PCSK9 / Hipercolesterolemia / LDL-Colesterol Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Am J Cardiovasc Drugs Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Inhibidores de PCSK9 / Hipercolesterolemia / LDL-Colesterol Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Am J Cardiovasc Drugs Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: Alemania